All Stories

  1. Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma

    Article • ERJ Open Research, September 2021, European Respiratory Society (ERS)

    Stephen noorduyn

  2. Exacerbations in chronic obstructive pulmonary disease (COPD) in Ontario, Canada

    Article • September 2021, European Respiratory Society (ERS)

    Stephen noorduyn

  3. Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma

    Article • September 2021, European Respiratory Society (ERS)

    Stephen noorduyn

  4. Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study

    Article • ERJ Open Research, January 2021, European Respiratory Society (ERS)

    Stephen noorduyn

  5. Real-world treatment patterns of mepolizumab therapy in Canada

    Article • September 2020, European Respiratory Society (ERS)

    Stephen noorduyn

  6. Over use of short acting beta agonists and impact on physician visits

    Article • September 2020, European Respiratory Society (ERS)

    Stephen noorduyn, Erika Penz